DIN 02432854 — DUAVIVE 0.45 MG; 20 MG
DUAVIVE is a tablet (immediate- and extended-release) of Conjugated Estrogens / Bazedoxifene marketed by PFIZER CANADA ULC. The full Conjugated Estrogens / Bazedoxifene monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02432854
- Brand name
- DUAVIVE
- Active ingredient
- Conjugated Estrogens / Bazedoxifene
- Strength
- 0.45 MG; 20 MG
- Dosage form
- TABLET (IMMEDIATE- AND EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Estrogenic hormone / selective estrogen receptor modulator (SERM) combination (tissue-selective estrogen complex)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.